Financial Notes to the company statements 117 financial statements Auditors report in respect of the Group 1.
Auditor fees 118 Consolidated income statement Note 3 to the consolidated financial statements of the group provides details of the remuneration of the companys auditor on a group basis.
Directors emoluments income Full information on directors emoluments, share and other interests, transactions and pension entitlements is included in the directors 120 Consolidated remuneration report in this Annual Report.
Investments Consolidated statement of million changes in equity Cost 122 At 30 June 2011 27,309 Consolidated statement of Additions 7 cash flows At 30 June 2012 27,316 123 Impairment losses Accounting policies of the group At 30 June 2012 and at 30 June 2011 286 127 Carrying amount Notes to the At 30 June 2012 27,030 consolidated financial statements At 30 June 2011 27,023 176 Auditors report in Details of the principal group companies are given after these financial statements.
Financial assets and liabilities 177 Company balance sheet Financial assets and liabilities comprise the fair value of interest rate swaps and cross currency interest rate swaps with 178 subsidiary undertakings.
Accounting policies of the company 5.
Provisions for liabilities and charges 180 Notes to the Vacant Total company financial Thalidomide properties provisions statements million million million 182 At 30 June 2011 152 1 153 Principal group Provision used during the year 14 1 15 companies Unwinding of discounts 9 9 At 30 June 2012 147 147 Provisions by their nature are subject to uncertainties with respect to the timing and outcomes of future events.
A provision was established in the year ended 30 June 2005 in respect of the discounted value of the companys commitment to the UK Thalidomide Trust, and will be utilised over the period of the commitment up to 2037.
Shareholders funds Profit and loss account Capital Total Share Share Merger redemption Own shareholders capital premium reserve reserve shares Other Total funds million million million million million million million million At 30 June 2011 797 1,343 9,161 3,146 2,255 4,414 2,159 16,606 Profit for the year 3,877 3,877 3,877 Employee share schemes 2 2 2 Share-based incentive plans 35 35 35 Shares issued 1 1 Dividends paid 1,036 1,036 1,036 At 30 June 2012 797 1,344 9,161 3,146 2,257 7,290 5,033 19,481 180 Diageo Annual Report 2012
